Free Trial
Ami Fadia

Ami Fadia Analyst Performance

Sr Biotech Equity Research Analyst at Needham & Company LLC

Ami Fadia is a stock analyst at Needham & Company LLC, covering 25 publicly traded companies across a range of sectors. Over the past year, Ami Fadia has issued 77 stock ratings, including buy and hold recommendations. While full access to Ami Fadia's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ami Fadia's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
108 Last 9 Years
Buy Recommendations
87.74% 93 Buy Ratings
Companies Covered
25 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy87.7%93 ratings
Hold12.3%13 ratings
Sell0.0%0 ratings

Out of 106 total stock ratings issued by Ami Fadia at Needham & Company LLC, the majority (87.7%) have been Buy recommendations, followed by 12.3% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
96.0% of companies on NASDAQ
24 companies
NYSE
4.0% of companies on NYSE
1 company

Ami Fadia, an analyst at Needham & Company LLC, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
25 companies
100.0%

Ami Fadia of Needham & Company LLC specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
17 companies
68.0%
MED - DRUGS
5 companies
20.0%
PHARMACEUTICAL PREPARATIONS
3 companies
12.0%

About Ami Fadia

Ami Fadia joined Needham and Company in May 2021 covering Biotechnology with a focus on targeted oncology and neuroscience. Prior to joining Needham, Ami spent four years as a Managing Director and Senior Analyst at SVB Leerink and previous to that spent six years at UBS where she most recently held the position of Senior Analyst. Ami also spent time working in industry as Head of Strategy & Operations at Sandoz where she was responsible for building a high performing team responsible for strategic planning, sales force strategy, training, project management, budgeting, and business development. Ami began her career in consulting working at KPMG and then McKinsey & Company in their healthcare practice. Ami holds an MBA from the Kellogg School of Management, her Bachelor’s of Commerce from the Shri Ram College, Delhi University and is a member of the Institute of Chartered Accountants of India.
Follow on LinkedIn

Ami Fadia's Ratings History at Needham & Company LLC

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Biogen Inc. stock logo
BIIB
Biogen
9/4/2025Reiterated Rating$141.62Hold
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
8/28/2025Reiterated Rating$124.43$202.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
8/26/2025Reiterated Rating$5.95$8.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
8/20/2025Reiterated Rating$119.20$202.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
8/7/2025Lower Price Target$36.67$56.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
8/6/2025Lower Price Target$6.88$16.00Buy
Merus N.V. stock logo
MRUS
Merus
8/6/2025Lower Price Target$67.45$96.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
8/4/2025Reiterated Rating$103.02$150.00Buy
Alkermes plc stock logo
ALKS
Alkermes
7/29/2025Reiterated Rating$26.15$45.00Buy
Alkermes plc stock logo
ALKS
Alkermes
7/21/2025Reiterated Rating$29.22$45.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
6/26/2025Reiterated Rating$22.50$30.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
6/24/2025Reiterated Rating$40.42$57.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
6/18/2025Reiterated Rating$1.82$9.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
6/17/2025Reiterated Rating$7.49Hold
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
6/16/2025Reiterated Rating$6.70Hold
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
6/12/2025Reiterated Rating$44.60$80.00Buy
Biogen Inc. stock logo
BIIB
Biogen
6/12/2025Reiterated Rating$133.06Hold
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
6/11/2025Reiterated Rating$113.00$202.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
6/9/2025Lower Price Target$111.91$150.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
6/5/2025Reiterated Rating$1.96$9.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
6/3/2025Reiterated Rating$108.29$202.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
6/2/2025Downgrade$101.15$130.00Hold
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
5/28/2025Initiated Coverage$12.77$35.00Buy
Alkermes plc stock logo
ALKS
Alkermes
5/28/2025Initiated Coverage$29.90$45.00Buy
Merus N.V. stock logo
MRUS
Merus
5/19/2025Reiterated Rating$41.56$75.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
5/19/2025Boost Price Target$22.26$30.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
5/13/2025Reiterated Rating$0.72$5.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
5/8/2025Reiterated Rating$37.66$57.00Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
5/8/2025Reiterated Rating$9.47$19.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
5/7/2025Lower Price Target$6.99$27.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
5/7/2025Reiterated Rating$111.17$200.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
5/6/2025Reiterated Rating$29.96$49.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
5/5/2025Reiterated Rating$40.24$80.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
5/2/2025Reiterated Rating$9.08$29.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
4/28/2025Lower Price Target$87.20$130.00Buy
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
4/25/2025Reiterated Rating$7.79Hold
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/15/2025Upgrade$94.89$138.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
4/10/2025Reiterated Rating$110.12$210.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
4/10/2025Reiterated Rating$1.29$12.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
4/10/2025Reiterated Rating$0.76$5.00Buy
Merus N.V. stock logo
MRUS
Merus
4/9/2025Reiterated Rating$34.89$83.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
4/9/2025Reiterated Rating$6.38$30.00Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
4/9/2025Reiterated Rating$6.59$19.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
4/8/2025Reiterated Rating$14.61$28.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
4/8/2025Reiterated Rating$80.20$133.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
4/8/2025Reiterated Rating$31.53$85.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
4/8/2025Reiterated Rating$31.40$59.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
4/8/2025Reiterated Rating$28.91$50.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
4/1/2025Reiterated Rating$116.63$153.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
3/21/2025Reiterated Rating$1.65$12.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
3/11/2025Reiterated Rating$9.79$30.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
3/5/2025Reiterated Rating$140.69$210.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
3/4/2025Reiterated Rating$1.41$5.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
3/3/2025Lower Price Target$38.60$85.00Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
3/3/2025Reiterated Rating$7.91$19.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
3/3/2025Reiterated Rating$129.15$153.00Buy
Merus N.V. stock logo
MRUS
Merus
2/28/2025Lower Price Target$46.22$83.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
2/27/2025Reiterated Rating$18.96$28.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
2/27/2025Lower Price Target$40.50$59.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
2/26/2025Boost Price Target$139.67$210.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
2/26/2025Reiterated Rating$11.10$30.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
2/26/2025Reiterated Rating$11.82$32.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
2/25/2025Reiterated Rating$34.18$50.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/19/2025Boost Price Target$128.09$153.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
2/19/2025Lower Price Target$36.76$50.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
2/13/2025Reiterated Rating$103.56$133.00Buy
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
2/12/2025Reiterated Rating$7.19Hold
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/10/2025Reiterated Rating$131.74$133.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
2/10/2025Reiterated Rating$86.88$150.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/7/2025Reiterated Rating$150.51Hold
Immuneering Corporation stock logo
IMRX
Immuneering
2/6/2025Reiterated Rating$2.03$12.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
1/13/2025Reiterated Rating$87.43$135.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
1/13/2025Reiterated Rating$35.91$52.00Buy
Intra-Cellular Therapies, Inc. stock logo
ITCI
Intra-Cellular Therapies
1/13/2025Reiterated Rating$127.74$100.00Hold
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
1/13/2025Reiterated Rating$14.75$32.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
1/13/2025Reiterated Rating$1.99$15.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
1/13/2025Reiterated Rating$11.77$33.00Buy